Publications by authors named "Felix Grabenbauer"

Claim this Profile
T
The Effect of Lurbinectedin as a Monotherapy and in Combination with Ionizing Radiation on Sarcoma Cell Lines.
Hannah Alsheimer, Paula Schiller, Sabine Semrau, Felix Grabenbauer, Rainer Fietkau

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing offline magnetic resonance-guided prostate radiotherapy through dedicated imaging and deep learning-based automatic contouring of targets and neurovascular structures.
Philipp Schubert, Matthias May, Daniel Höfler, Hans-Peter Fautz, Jana Hutter, Felix Grabenbauer

Phys Imaging Radiat Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Through the labyrinth towards the goal: doxorubicin/trabectedin in metastatic and initially unresectable leiomyosarcoma].
Felix Grabenbauer, Sabine Semrau

Strahlenther Onkol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of dual-energy computed tomography derived virtual monoenergetic imaging for target volume delineation of brain metastases.
Johannes Kraft, Paul Lutyj, Felix Grabenbauer, Serge-Peer Ströhle, Jörg Tamihardja

Radiother Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Organ-preserving treatment of muscle-invasive bladder cancer: 10-year data of the British BC2001 study].
Felix Grabenbauer, Michael Flentje

Strahlenther Onkol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Salvage prostate bed radiotherapy: co-irradiation of regional LNs and significance of ADT].
Felix Grabenbauer, Michael Flentje

Strahlenther Onkol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule.
Felix Grabenbauer, Astrid Katzer, Dmitri Sisario, Simon Memmel, Michael Flentje

Oncotarget· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis